Figures computed from official regulatory filings — .
Insufficient history for a statistical track record (fewer than 5 open-market buys).
This page republishes public regulatory disclosures.
| Company | Type | Value · USD | Signals | Details | |
|---|---|---|---|---|---|
Tango Therapeutics, Inc.Listing on record | Sell | $2.1M | SEC | ||
Tango Therapeutics, Inc.Listing on record | Sell | $7.7M | Unusual size | SEC | |
Tango Therapeutics, Inc.Listing on record | Sell | $1.5M | SEC | ||
Tango Therapeutics, Inc.Listing on record | Sell | $1.3M | SEC | ||
Tango Therapeutics, Inc.Listing on record | Sell | $392K | SEC | ||
Tango Therapeutics, Inc.Listing on record | Sell | $993K | SEC | ||
Tango Therapeutics, Inc.Listing on record | Sell | $931K | SEC | ||
Tango Therapeutics, Inc.Listing on record | Sell | $1.2M | SEC | ||
Tango Therapeutics, Inc.Listing on record | Sell | $2.6M | SEC | ||
Tango Therapeutics, Inc.Listing on record | Sell | $5.4M | SEC | ||
Dianthus Therapeutics, Inc. /DE/Listing on record | Other | n/a (No price was disclosed in the filing) | SEC | ||
Fulcrum Therapeutics, Inc.Listing on record | Other | n/a (No price was disclosed in the filing) | SEC | ||
Fulcrum Therapeutics, Inc.Listing on record | OtherD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC | ||
Fulcrum Therapeutics, Inc.Listing on record | Buy | $1.3M | conv 51ClusterFirst in 12mo | SEC | |
Dianthus Therapeutics, Inc. /DE/Listing on record | OtherD (derivative) | n/a (No price was disclosed in the filing) | SEC | ||
Dianthus Therapeutics, Inc. /DE/Listing on record | Other | n/a (No price was disclosed in the filing) | SEC | ||
Dianthus Therapeutics, Inc. /DE/Listing on record | OtherD (derivative) | n/a (No price was disclosed in the filing) | SEC |